Streptozotocin treatment of streptozotocin-induced islet cell adenomas in rats.
Hypoglycemic rats bearing insulin-secreting islet-cell adenomas produced by the combined action of streptozotocin and nicotinamide were treated with streptozotocin. Antitumor response was demonstrated by elevation of blood glucose, reduction in plasma and tumor IRI, and histopathologic changes in the beta-cell neoplasm. The rodent tumor model may serve as a predictive system for selection and investigation of mechanisms of action of future antitumor agents to be used in the treatment of malignant insulinoma in man.
D007516:Adenoma, Islet Cell / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D007328:Insulin / Q000097:blood; D009536:Niacinamide; D051381:Rats; D013311:Streptozocin / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D009536:Niacinamide; D013311:Streptozocin